Martin Schiffenbauer v. Myovant Sciences Ltd. et al: Complaint (‘Securities Fraud’)

Complaint alleging securities fraud in Martin Schiffenbauer v. Myovant Sciences Ltd., described as a Bermuda “pharmaceutical company” based in London, England; Terrie Curran, Mark Guinan, Adele M. Gulfo, Dave Marek, Shigeyuki Nishinaka, Myrtle Potter, and Nancy Valente at the U.S. District Court for the Southern District of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 17

Date: December 11, 2022

Defendants/Respondents: Myovant Sciences Ltd., Terrie Curran, Mark Guinan, Adele M. Gulfo, Dave Marek, Shigeyuki Nishinaka, Myrtle Potter, Nancy Valente

Plaintiffs/Applicants: Martin Schiffenbauer

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities

Allegation: Fraud

Plaintiffs/Applicants Attorneys: Wohl & Fruchter, Joshua Fruchter

Topics

Bermuda England Fraud Investment Listed Securities

USA United Kingdom

[ 2 more... ] [ top 5 ]

Keywords

Adele Gulfo Dave Marek Mark Guinan Myovant Sciences Myrtle Potter

Nancy Valente Shigeyuki Nishinaka Sumitovant Biopharma Terrie Curran

[ 4 more... ] [ top 5 ]

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.